Development and optimization of asiaticoside co-crystal-loaded transdermal patch for topical therapy.

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Dermatology

Background:

• Asiaticoside is a promising compound for wound healing, but its topical application is limited by poor solubility and mechanical properties.
• Transdermal patches offer a non-invasive drug delivery system for sustained topical therapy.

Purpose of the Study:

• To develop and optimize a hydrogel-based transdermal patch incorporating asiaticoside co-crystals.
• To enhance asiaticoside's solubility, mechanical properties, and achieve sustained release for effective wound management.
• To evaluate the physicochemical, biological, and stability performance of the developed transdermal patch.

Main Methods:

• Asiaticoside co-crystals were prepared using solvent evaporation with succinic acid.
• Hydrogel transdermal patches were formulated using HPMC K100M and PEG 400.
• A 3^2 full factorial design optimized excipient concentrations, followed by comprehensive physicochemical, in vitro, and in vivo evaluations.

Main Results:

• Co-crystal formation was confirmed by DSC and FTIR, showing improved properties.
• The optimized patch (F2) exhibited desirable thickness (0.36 mm) and folding endurance (216) with low errors.
• In vitro release was 95.2% over 12h, following Hixson-Crowell kinetics and Fickian diffusion.
• In vivo studies showed no skin irritation and wound contraction of 95.0% by day 9.
• Accelerated stability studies indicated minimal changes over 3 months.

Conclusions:

• The developed asiaticoside co-crystal transdermal patch is a promising, non-irritant system for wound care.
• The patch offers sustained drug release, enhanced healing efficacy, and improved patient compliance.
• Further pharmacokinetic and translational studies are warranted to explore its clinical potential.